Minerva Neurosciences

NERV

Market cap $206M

NERV Hedge Fund Activity: Q1 2026 in Review

47 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2026, worth a combined $231M — up 114% from $108M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new NERV positions and 3 closed out — a net gain of 15 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $24.6M. The largest seller was Adage Capital Partners, cutting an estimated $8.14M.

• 47 institutional investors held Minerva Neurosciences (NERV) as of Q1 2026, up from 33 in Q4 2025.
• Funds reported $231M of Minerva Neurosciences stock for Q1 2026, up 114% quarter-over-quarter.
• 18 funds opened new Minerva Neurosciences positions in Q1 2026 and 3 closed out, a net change of +15 holders.
• The largest Minerva Neurosciences buyer in Q1 2026 was Janus Henderson Group, an estimated $24.6M added.
• The largest Minerva Neurosciences seller in Q1 2026 was Adage Capital Partners, an estimated $8.14M sold.

Based on aggregated 13F filings for Q1 2026.